ImageneBio Inc (IMA)

Currency in USD
15.750
-0.740(-4.49%)
Closed·
After Hours
15.7500.000(0.00%)
·
IMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.75016.470
52 wk Range
11.64823.280
Key Statistics
Prev. Close
15.75
Open
16.47
Day's Range
15.75-16.47
52 wk Range
11.648-23.28
Volume
2.76K
Average Volume (3m)
20.27K
1-Year Change
-20.45%
Book Value / Share
2.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

ImageneBio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ImageneBio Inc Company Profile

Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. As of July 25, 2025, Ikena Oncology, Inc. was acquired by Inmagene Biopharmaceuticals Co. Ltd.

Compare IMA to Peers and Sector

Metrics to compare
IMA
Peers
Sector
Relationship
P/E Ratio
−2.2x0.0x−0.5x
PEG Ratio
−0.040.000.00
Price/Book
0.6x0.0x2.6x
Price / LTM Sales
-0.0x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock0.0%6.9%Unlock

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
-0.69 / -0.1417
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IMA Income Statement

People Also Watch

0.989
GAME
+13.82%
16.26
SRPT
-2.93%
430.37
MEDP
-1.36%
5.50
REPL
-12.97%
0.365
VYNE
+1.39%

FAQ

What Stock Exchange Does ImageneBio Trade On?

ImageneBio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ImageneBio?

The stock symbol for ImageneBio is "IMA."

What Is the ImageneBio Market Cap?

As of today, ImageneBio market cap is 159.40M.

What Is ImageneBio's Earnings Per Share (TTM)?

The ImageneBio EPS (TTM) is -7.64.

When Is the Next ImageneBio Earnings Date?

ImageneBio will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is IMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ImageneBio Stock Split?

ImageneBio has split 1 times.

How Many Employees Does ImageneBio Have?

ImageneBio has 9 employees.

What is the current trading status of ImageneBio (IMA)?

As of 07 Aug 2025, ImageneBio (IMA) is trading at a price of 15.75, with a previous close of 15.75. The stock has fluctuated within a day range of 15.75 to 16.47, while its 52-week range spans from 11.65 to 23.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.